Effects of acute and sub-chronic l-dopa therapy on striatal l-dopa methylation and dopamine oxidation in an MPTP mouse model of Parkinsons disease

MAO-B Elevation in Mouse Brain Astrocytes Results in Parkinson's Pathology

Jyothi K. Mallajosyula, Deepinder Kaur, Shankar J. Chinta et al. · PLoS ONE · 2008 · 275 citations · Full text

Unregulated Cytosolic Dopamine Causes Neurodegeneration Associated with Oxidative Stress in Mice

Linan Chen, Yunmin Ding, Barbara Cagniard et al. · Journal of Neuroscience · 2008 · 236 citations · Full text

3-OMD and homocysteine plasma levels in parkinsonian patients.

Th. Müller, Dirk Woitalla, Brian Fowler et al. · Journal of Neural Transmission · 2002 · 129 citations

Neurodegenerative Diseases, Homocysteine Plasma Levels, Parkinson Disease +6

Optimizing levodopa therapy for Parkinson’s disease with levodopa/carbidopa/entacapone: implications from a clinical and patient perspective

David J. Brooks · Neuropsychiatric Disease and Treatment · 2008 · 106 citations · Full text

Plasma Half-life, Neurodegenerative Diseases, Translational Medicine +15

Does monoamine oxidase type B play a role in dopaminergic nerve cell death in Parkinson's disease?

Philippe Damier, Anne Kästner, Yves Agid et al. · Neurology · 1996 · 76 citations